GC Corp. (KRX:005250)
South Korea · Delayed Price · Currency is KRW 9,230.00
+90.00 (0.98%)
Nov 2, 2026, 3:30 PM KST
GC Corp. Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,487,390 | 2,451,476 | 2,204,855 | 2,057,936 | 2,079,560 | 1,840,559 |
Revenue Growth | 9.57% | 11.19% | 7.14% | -1.04% | 12.98% | 7.05% |
Gross Profit Gross Profit Growth | 679,069 | 680,696 | 618,266 | 601,668 | 696,018 | 626,899 |
Operating Income Operating Income Growth | 29,262 | 34,990 | -10,987 | -21,830 | 71,023 | 85,999 |
Net Income Net Income Growth | -121,264 | -68,798 | 24,025 | -54,136 | 32,656 | 54,901 |
Earnings Per Share EPS Growth | -2670.92 | -1515.32 | 529.17 | -1192.38 | 719.27 | 1209.24 |
EPS Growth | - | - | - | - | -40.52% | -67.79% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Development and supply of medical services and systems Development and supply of medical services and systems Growth | 249,951 | 240,538 | 229,549 | 191,663 | 166,042 | 141,569 |
Manufacturing and Sales of Pharmaceuticals, Etc. Manufacturing and Sales of Pharmaceuticals, Etc. Growth | 2,026,094 | 2,020,902 | 1,633,616 | 1,507,856 | 1,530,200 | 1,447,466 |
Connection Adjustment Connection Adjustment Growth | -278,137 | -316,077 | -212,030 | -152,986 | -156,801 | -165,829 |
Diagnosis and Analysis of Samples, Etc. Diagnosis and Analysis of Samples, Etc. Growth | 212,022 | 215,149 | 209,127 | 220,290 | 264,374 | 187,367 |
Rental and Service Industry Rental and Service Industry Growth | 68,313 | 64,141 | 61,817 | 59,707 | 66,770 | 73,934 |
Other Other Growth | 209,146 | 226,823 | 282,776 | 231,406 | 208,975 | 156,052 |
Total Total Growth | 2,487,389 | 2,451,476 | 2,204,855 | 2,057,936 | 2,079,560 | 1,840,559 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 107,815 | 99,283 | 84,098 | 196,111 | 239,977 | 398,394 |
Total Debt Total Debt Growth | 1,691,168 | 1,493,296 | 1,126,126 | 1,280,166 | 1,097,872 | 1,045,784 |
Net Cash (Debt) Net Cash Growth | -1,583,353 | -1,394,012 | -1,042,028 | -1,084,055 | -857,894 | -647,390 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -34874.29 | -30703.94 | -22951.28 | -23876.95 | -18895.63 | -14259.15 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 164,168 | 24,300 | -89,948 | -39,655 | 97,157 | 103,769 |
Capital Expenditures CapEx Growth | -127,112 | -110,893 | -43,890 | -89,962 | -73,216 | -116,600 |
Free Cash Flow Free Cash Flow Growth | 37,056 | -86,593 | -133,838 | -129,617 | 23,941 | -12,831 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.30% | 27.77% | 28.04% | 29.24% | 33.47% | 34.06% |
Operating Margin | 1.18% | 1.43% | -0.50% | -1.06% | 3.42% | 4.67% |
Pretax Margin | -5.45% | -2.18% | 1.93% | -3.94% | 1.46% | 9.78% |
Profit Margin | -4.88% | -2.81% | 1.09% | -2.63% | 1.57% | 2.98% |
FCF Margin | 1.49% | -3.53% | -6.07% | -6.30% | 1.15% | -0.70% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 300.000 | 300.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 3.25% | 1.89% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 32.73 | - | 23.64 | 22.45 |
P/FCF Ratio | 11.21 | - | - | - | 32.24 | - |
PS Ratio | 0.17 | 0.30 | 0.36 | 0.36 | 0.37 | 0.67 |